Scientists have revealed that a new breakthrough drug would clear tumours from patients suffering from kidney cancer. The new drug was made by combining two powerful agents – ipilimumab and nivolumab.
After a four month treatment system, a small-scale trial found that giving ipilimumab and nivolumab together cleared tumours from up to a tenth of patients whose kidney cancer had spread to other organs. These combination also made tumours disappear in 40 percent of these patients.
According to Professor John Wagstaff from the Swansea University Medical School, UK, “This is probably a breakthrough. It has the potential to improve and prolong the lives of thousands of patients.
“I hope the apparent benefit of combining ipilimumab and nivolumab would be confirmed in subsequent trials.”
In high hopes, Malcolm Packer, of Charity Kidney Cancer, UK said, “We welcome the progress now being made in fighting kidney cancer, because there are so few options at the moment.”